Publications by authors named "Moritz Heinz"

Claim this Profile
A
A Phase 1 randomized, open-label clinical trial to evaluate the effect of a far-infrared emitting patch on local skin perfusion, microcirculation and oxygenation.
Sebastiaan J W van Kraaij, Michael R Hamblin, Gisele Pickering, Bill Giannokopoulos, Hayet Kechemir, Moritz Heinz

Exp Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
C William Hanke, Rhoda S Narins, Fredric Brandt, Joel L Cohen, Lisa M Donofrio, Moritz Heinz

Dermatol Surg· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
Alastair Carruthers, Jean Carruthers, William P Coleman, Lisa Donofrio, Timothy Flynn, Moritz Heinz

Dermatol Surg· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results for incobotulinumtoxinA in the treatment of glabellar frown lines.
Berthold Rzany, Timothy Corcoran Flynn, Andrea Schlöbe, Moritz Heinz, Laura Harrington

Dermatol Surg· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database.
Martin Daumer, Ulrike Held, Katja Ickstadt, Moritz Heinz, Siegfried Schach

BMC Med Res Methodol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis